Co-diagnostics designs test to detect mutations for new coronavirus strain using coprimer™ platform

Salt lake city, dec. 22, 2020 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has completed principal design work for a pcr test...
CODX Ratings Summary
CODX Quant Ranking